VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹392 Cr | ₹358 Cr | ₹305 Cr | ₹273 Cr | ₹245 Cr |
What is the latest Total Liabilities ratio of VIMTA LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹392 Cr |
| Mar2023 | ₹358 Cr |
| Mar2022 | ₹305 Cr |
| Mar2021 | ₹273 Cr |
| Mar2020 | ₹245 Cr |
How is Total Liabilities of VIMTA LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹392 Cr | 9.56 | |
| Mar2023 | ₹358 Cr | 17.33 | |
| Mar2022 | ₹305 Cr | 11.61 | |
| Mar2021 | ₹273 Cr | 11.47 | |
| Mar2020 | ₹245 Cr | - | |
Compare Total Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,911.1 Cr | 3.5% | -12.5% | -18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 3.5% |
-12.5% |
-18.1% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses